QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PGNY

QT83Progyny, Inc.
NASDAQ·Healthcare·Medical - Healthcare Information Services·USA
Latest market price
26.08
-0.23-0.87%
OverviewShort InterestFilings
PGNYQT83Progyny, Inc.·NASDAQ
OverviewShort InterestFilings
26.08-0.87%
TA
Loading chart...
Screen all →
GEHC+0.72%$61.59VEEV-1.00%$153.30BTSG+2.82%$66.25TEM+4.20%$50.84HQY-1.30%$85.21HNGE+3.55%$69.42TXG+8.19%$34.76DOCS+0.05%$20.46
Snapshot
Index-P/E31.45EPS (ttm)
0.77
Insider Own20.10%
Shs Outstand78.33M
Perf Week1.68%
Market Cap2.06BForward P/E17.59EPS next Y1.48Insider Trans-0.05%Shs Float-Perf Month6.02%
Enterprise Value1.96BPEG0.90EPS next Q0.50Inst Own-Short Float-Perf Quarter43.45%
Income65.54MP/S1.59EPS this Y66.10%Inst Trans-Short Ratio-Perf Half Y0.27%
Sales1.29BP/B4.85EPS next Y15.95%ROA9.69%Short Interest-Perf YTD1.56%
Book/sh5.60P/C10.32EPS next 5Y8.15%ROE13.34%52W High28.75 -9.29%Perf Year21.13%
Cash/sh2.89P/FCF11.18EPS past 3/5Y-ROIC13.23%52W Low16.10 61.99%Perf 3Y-
Dividend Est.-EV/EBITDA17.60Sales past 3/5Y17.88% 30.16%Gross Margin24.11%Volatility2.62% 2.39%Perf 5Y-
Dividend TTM-EV/Sales1.51EPS Y/Y TTM140.35%Oper. Margin7.46%ATR (14)0.90Perf 10Y-
Dividend Ex-Date-Quick Ratio2.13Sales Y/Y TTM10.80%Profit Margin5.23%RSI (14)61.87Recom2.14
Dividend Gr. 3/5Y-Current Ratio2.13EPS Q/Q-39.58%SMA201.32%Beta0.61Target Price30.33
Payout0.00%Debt/Eq0.06Sales Q/Q1.54%SMA5017.74%Rel Volume1.93Prev Close26.31
Employees675LT Debt/Eq0.05EarningsAug 06SMA20018.11%Avg Volume1.58MPrice26.08
IPO DateOct 25, 2019Option/ShortYes / YesEPS/Sales Surpr.13.28% 0.92%Net Debt/EBITDA-0.95Volume3,065,058Change-0.87%
Analyst Ratings
DateActionAnalystRatingTarget
May-19-26UpgradeCanaccord GenuityHold → Buy$23 → $30
Mar-06-26ReiteratedJefferiesBuy$19 → $30
Mar-02-26ReiteratedTruist Financial$34 → $28
Jan-21-26ReiteratedJ.P. MorganNeutral$30 → $35
Jan-20-26UpgradeCitizensMarket Perform → Market Outperform
Jan-08-26ReiteratedTruist Financial$27 → $34
Jan-08-26ReiteratedKeybancOverweight$30 → $32
Dec-08-25InitiatedBarclaysOverweight$29
Nov-12-25UpgradeKeybancSector Weight → Overweight$30
Aug-08-25ReiteratedRaymond James$28
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,2931,2891,167
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A982984914
Gross Profit312304253
Selling, General and Administrative Excl. Other216219186
Research and Development
000
Other Operating Expense
000
Operating Income968567
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-10-10-16
Net Income Before Taxes1069583
Income Taxes383729
Consolidated Net Income675954
Net Income From Continuing Operations675954
Net Income675954
EPS (Recurring)0.810.680.59
EPS (Basic, Before Extraordinaries)0.810.680.59
EPS (Diluted)0.770.650.57
EBITDA11010086
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio33.8739.51—
Price To Sales Ratio1.631.69—
Gross Margin24.1323.5821.68
Operating Margin7.426.595.74
Net Margin5.184.584.63
Shares Outstanding818591
Market Capitalization2,1122,183—
Operating Lease Expense
———
Insider Trading Volume
$28.04$25.66$23.29$20.92$18.55● Close Price0.00M0.48M0.97M1.45M1.93MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Swartz AllisonEVP, GCJun 04 '26Sale25.0859915,02382,378Jun 05 12:00 AM
Livingston Mark S.CHIEF FINANCIAL OFFICERJun 04 '26Sale25.502,51764,18474,688Jun 05 12:00 AM
Swartz AllisonEVP, GCJun 03 '26Sale25.021,19929,99983,316Jun 05 12:00 AM
Swartz AllisonEVP, GCMay 28 '26Sale25.462,39861,05385,191Jun 01 12:00 AM
GORDON KEVIN KDirectorMay 27 '26Sale24.995,500137,4459,318May 29 12:00 AM
Livingston Mark S.CHIEF FINANCIAL OFFICERMay 20 '26Sale25.508,275211,01379,063May 21 12:00 AM
Cummings Melissa BChief Operating OfficerMay 19 '26Sale25.009,578239,45073,371May 21 12:00 AM
Swartz AllisonEVP, GCMar 04 '26Sale17.5459910,50688,941Mar 06 12:00 AM
Swartz AllisonEVP, GCMar 03 '26Sale17.404,65781,03089,879Mar 04 12:00 AM
Swartz AllisonEVP, GCMar 02 '26Sale17.272,19937,97797,378Mar 04 12:00 AM
Livingston Mark S.CHIEF FINANCIAL OFFICERDec 11 '25Sale25.5045911,70546,983Dec 15 12:00 AM
Swartz AllisonEVP, GCDec 04 '25Sale24.5953013,03372,719Dec 08 12:00 AM
Livingston Mark S.CHIEF FINANCIAL OFFICERDec 02 '25Sale25.502135,43247,921Dec 04 12:00 AM
Swartz AllisonEVP, GCNov 28 '25Sale26.872,39864,43473,657Dec 02 12:00 AM
Livingston Mark S.CHIEF FINANCIAL OFFICERNov 17 '25Sale25.5021,303543,22748,358Nov 19 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR